Streptococcus pseudopneumoniae: an emerging respiratory tract pathogen

J Sariya Mohammadi1, B Dhanashree

  • 1Department of Microbiology, Kasturba Medical College, Manipal University, Mangalore, India.

Abstract

Insights

Streptococcus pseudopneumoniae was identified in Indian respiratory tract infection samples and showed erythromycin resistance. Accurate identification requires specific tests to differentiate it from Streptococcus pneumoniae.

Area of Science:

  • Medical Microbiology
  • Bacteriology
  • Infectious Diseases

Background:

  • Streptococcus pseudopneumoniae, a Viridans Streptococci member, is linked to chronic obstructive pulmonary disease and respiratory tract infections (RTI).
  • Limited data exists on S. pseudopneumoniae isolation in India.

Purpose of the Study:

  • To isolate S. pseudopneumoniae from clinical samples in India.
  • To determine the drug resistance patterns of S. pseudopneumoniae isolates.

Main Methods:

  • Sputum samples (n=150) from patients with suspected lower respiratory tract infections were cultured.
  • Identification of S. pseudopneumoniae involved assessing capsule absence, bile solubility, and optochin susceptibility under specific atmospheric conditions.
  • Antibiotic susceptibility testing was performed using the disk diffusion method.

Main Results:

  • S. pseudopneumoniae was isolated from 4% of the screened samples.
  • All S. pseudopneumoniae isolates exhibited resistance to erythromycin.
  • Other co-isolated pathogens included Streptococcus pneumoniae, Moraxella catarrhalis, and Klebsiella spp.

Conclusions:

  • S. pseudopneumoniae is present in India and associated with RTIs.
  • Standard laboratory methods may misidentify S. pseudopneumoniae as S. pneumoniae.
  • Accurate differentiation requires optochin susceptibility testing in both 5% CO₂ and ambient air, along with bile solubility tests.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.